However, the risk of fatal stroke was comparable between GLP-1 RA and placebo groups (OR, 0.94(95 %CI: 0.75–1.17), P = 0.56), I2 = 0) (Fig. 3A-B). This evidence concerns the gene GLP1R and stroke disorder.